Ajila, Vidya, Harish Shetty, Subhas Babu, Veena Shetty, and Shruthi Hegde. 2015. ‘Human Papilloma Virus Associated Squamous Cell Carcinoma of the Head and Neck’. Journal of Sexually Transmitted Diseases 2015:1–5. doi: 10.1155/2015/791024.
Barrett, David M., Stephan A. Grupp, and Carl H. June. 2015. ‘Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street’. The Journal of Immunology 195(3):755–61. doi: 10.4049/jimmunol.1500751.
Ecker, Dawn M., Susan Dana Jones, and Howard L. Levine. 2015. ‘The Therapeutic Monoclonal Antibody Market’. mAbs 7(1):9–14. doi: 10.4161/19420862.2015.989042.
Gill, Saar, and Carl H. June. 2015. ‘Going Viral: Chimeric Antigen Receptor T-Cell Therapy for Hematological Malignancies’. Immunological Reviews 263(1):68–89. doi: 10.1111/imr.12243.
Grupp, Stephan A., Michael Kalos, David Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, and Carl H. June. 2013. ‘Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia’. New England Journal of Medicine 368(16):1509–18. doi: 10.1056/NEJMoa1215134.
Hanahan, Douglas, and Robert A. Weinberg. 2000. ‘The Hallmarks of Cancer’. Cell 100(1):57–70. doi: 10.1016/S0092-8674(00)81683-9.
zur Hausen, Harald. 2009. ‘Papillomaviruses in the Causation of Human Cancers — a Brief Historical Account’. Virology 384(2):260–65. doi: 10.1016/j.virol.2008.11.046.
Hodi, F. Stephen, Steven J. O’Day, David F. McDermott, Robert W. Weber, Jeffrey A. Sosman, John B. Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C. Hassel, Wallace Akerley, Alfons J. M. van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M. Vaubel, Gerald P. Linette, David Hogg, Christian H. Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I. Clark, Jedd D. Wolchok, Jeffrey S. Weber, Jason Tian, Michael J. Yellin, Geoffrey M. Nichol, Axel Hoos, and Walter J. Urba. 2010. ‘Improved Survival with Ipilimumab in Patients with Metastatic Melanoma’. New England Journal of Medicine 363(8):711–23. doi: 10.1056/NEJMoa1003466.
Jeggo, Penny A., Laurence H. Pearl, and Antony M. Carr. 2015. ‘DNA Repair, Genome Stability and Cancer: A Historical Perspective’. Nature Reviews Cancer 16(1):35–42. doi: 10.1038/nrc.2015.4.
Kaufman, Howard L., Frederick J. Kohlhapp, and Andrew Zloza. 2015. ‘Oncolytic Viruses: A New Class of Immunotherapy Drugs’. Nature Reviews Drug Discovery 14(9):642–62. doi: 10.1038/nrd4663.
Klebanoff, Christopher A., Steven A. Rosenberg, and Nicholas P. Restifo. 2016. ‘Prospects for Gene-Engineered T Cell Immunotherapy for Solid Cancers’. Nature Medicine 22(1):26–36. doi: 10.1038/nm.4015.
Koebel, Catherine M., William Vermi, Jeremy B. Swann, Nadeen Zerafa, Scott J. Rodig, Lloyd J. Old, Mark J. Smyth, and Robert D. Schreiber. 2007. ‘Adaptive Immunity Maintains Occult Cancer in an Equilibrium State’. Nature 450(7171):903–7. doi: 10.1038/nature06309.
Larson, Christopher, Bryan Oronsky, Jan Scicinski, Gary R. Fanger, Meaghan Stirn, Arnold Oronsky, and Tony R. Reid. 2015. ‘Going Viral: A Review of Replication-Selective Oncolytic Adenoviruses’. Oncotarget 6(24). doi: 10.18632/oncotarget.5116.
Lazebnik, Yuri. 2010. ‘What Are the Hallmarks of Cancer?’ Nature Reviews Cancer 10(4):232–33. doi: 10.1038/nrc2827.
Lingyun Geng. 2015. ‘Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Experimental and Clinical Developments’. International Journal of Clinical and Experimental Medicine 8(9).
de Martel, Catherine, Jacques Ferlay, Silvia Franceschi, Jérôme Vignat, Freddie Bray, David Forman, and Martyn Plummer. 2012. ‘Global Burden of Cancers Attributable to Infections in 2008: A Review and Synthetic Analysis’. The Lancet Oncology 13(6):607–15. doi: 10.1016/S1470-2045(12)70137-7.
Matsuoka, M., and K. T. Jeang. 2011. ‘Human T-Cell Leukemia Virus Type 1 (HTLV-1) and Leukemic Transformation: Viral Infectivity, Tax, HBZ and Therapy’. Oncogene 30(12):1379–89. doi: 10.1038/onc.2010.537.
Morris, Emma C., and Hans J. Stauss. 2016. ‘Optimizing T-Cell Receptor Gene Therapy for Hematologic Malignancies’. Blood 127(26):3305–11. doi: 10.1182/blood-2015-11-629071.
Palucka, Karolina, and Jacques Banchereau. 2012. ‘Cancer Immunotherapy via Dendritic Cells’. Nature Reviews Cancer 12(4):265–77. doi: 10.1038/nrc3258.
Pierangeli, A., G. Antonelli, and G. Gentile. 2015. ‘Immunodeficiency-Associated Viral Oncogenesis’. Clinical Microbiology and Infection 21(11):975–83. doi: 10.1016/j.cmi.2015.07.009.
Reichert, Janice M. 2012. ‘Marketed Therapeutic Antibodies Compendium’. mAbs 4(3):413–15. doi: 10.4161/mabs.19931.
Reichert, Janice M. 2016. ‘Antibodies to Watch in 2016’. mAbs 8(2):197–204. doi: 10.1080/19420862.2015.1125583.
Reichert, Janice M. 2017. ‘Antibodies to Watch in 2017’. mAbs 9(2):167–81. doi: 10.1080/19420862.2016.1269580.
Restifo, Nicholas P., Mark E. Dudley, and Steven A. Rosenberg. 2012. ‘Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response’. Nature Reviews Immunology 12(4):269–81. doi: 10.1038/nri3191.
Robbins, Paul F., Richard A. Morgan, Steven A. Feldman, James C. Yang, Richard M. Sherry, Mark E. Dudley, John R. Wunderlich, Azam V. Nahvi, Lee J. Helman, Crystal L. Mackall, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi-Chia Richard Lee, Catherine L. Levy, Yong F. Li, Mona El-Gamil, Susan L. Schwarz, Carolyn Laurencot, and Steven A. Rosenberg. 2011. ‘Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1’. Journal of Clinical Oncology 29(7):917–24. doi: 10.1200/JCO.2010.32.2537.
Robert D. Schreiber, Lloyd J. Old and Mark J. Smyth. 2011. ‘Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion’. Science 331(6024):1565–70.
Roos, Wynand P., Adam D. Thomas, and Bernd Kaina. 2015. ‘DNA Damage and the Balance between Survival and Death in Cancer Biology’. Nature Reviews Cancer 16(1):20–33. doi: 10.1038/nrc.2015.2.
Russell, Stephen J., Kah-Whye Peng, and John C. Bell. 2012. ‘Oncolytic Virotherapy’. Nature Biotechnology 30(7):658–70. doi: 10.1038/nbt.2287.
Schinzari, V., V. Barnaba, and S. Piconese. 2015. ‘Chronic Hepatitis B Virus and Hepatitis C Virus Infections and Cancer: Synergy between Viral and Host Factors’. Clinical Microbiology and Infection 21(11):969–74. doi: 10.1016/j.cmi.2015.06.026.
Schumacher, T. N., and R. D. Schreiber. 2015. ‘Neoantigens in Cancer Immunotherapy’. Science 348(6230):69–74. doi: 10.1126/science.aaa4971.
Shankaran, Vijay, Hiroaki Ikeda, Allen T. Bruce, J. Michael White, Paul E. Swanson, Lloyd J. Old, and Robert D. Schreiber. 2001. ‘IFNγ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity’. Nature 410(6832):1107–11. doi: 10.1038/35074122.
Spurgeon, Megan E., and Paul F. Lambert. 2013. ‘Merkel Cell Polyomavirus: A Newly Discovered Human Virus with Oncogenic Potential’. Virology 435(1):118–30. doi: 10.1016/j.virol.2012.09.029.
Topalian, Suzanne L., F. Stephen Hodi, Julie R. Brahmer, Scott N. Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott J. Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure-Kunkel, Shruti Agrawal, Daniel McDonald, Georgia D. Kollia, Ashok Gupta, Jon M. Wigginton, and Mario Sznol. 2012. ‘Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer’. New England Journal of Medicine 366(26):2443–54. doi: 10.1056/NEJMoa1200690.
Varghese, Susan, and Samuel D. Rabkin. 2002. ‘Oncolytic Herpes Simplex Virus Vectors for Cancer Virotherapy’. Cancer Gene Therapy 9(12):967–78. doi: 10.1038/sj.cgt.7700537.
Weinberg, Robert A. 2014. The Biology of Cancer. 2nd ed. New York: Garland Science.
Weiss, Robin A., and Peter K. Vogt. 2011. ‘100 Years of Rous Sarcoma Virus’. The Journal of Experimental Medicine 208(12):2351–55. doi: 10.1084/jem.20112160.
Wendzicki, Justin A., Patrick S. Moore, and Yuan Chang. 2015. ‘Large T and Small T Antigens of Merkel Cell Polyomavirus’. Current Opinion in Virology 11:38–43. doi: 10.1016/j.coviro.2015.01.009.
